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ABSTRACT 
Adherence to Continuous Positive Airway Pressure (CPAP) therapy for Obstructive 
Sleep Apnoea (OSA) is often poor. Biomedical indices explain little of the variance in 
CPAP use. This study tested a Health Beliefs model of adherence to determine the 
contribution of psychological constructs as compared to biomedical indices in the 
prediction of CPAP adherence.  
77 consecutive patients newly diagnosed with OSA and were naive to CPAP treatment 
(had never tried CPAP before) completed questionnaires at baseline (prior to CPAP 
treatment). Questionnaires assessed; outcome expectancy with treatment, self-efficacy, 
functional outcomes of sleepiness, and perceived risk of negative health outcomes. 
Physiological data from standard clinical diagnostic sleep study was obtained. CPAP 
adherence was assessed at 4 month follow-up.  
Health Beliefs Model constructs alone explained 21.8% of the variance in CPAP 
adherence (p<.01), whilst Health Beliefs Model constructs and biomedical indices 
together explained 31.8% of the variance in CPAP adherence (p=.01). The greatest 
proportion of CPAP adherence was explained by higher outcome expectancies with 
treatment, greater functional limitations as a result of sleepiness and lower risk 
perception.  
Results suggest that patients have developed beliefs and expectations about OSA and 
CPAP even before they have tried CPAP treatment. These beliefs and expectations 
predict patients’ adherence to effective therapy.  
 
Key words: CPAP treatment, Obstructive Sleep Apnea, Psychological Models, 
Adherence, Prediction
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INTRODUCTION 
Obstructive Sleep Apnoea (OSA) is a common sleep disorder characterised by collapse 
of the upper airway during sleep.1, 2 The estimated American prevalence of OSA is 4% 
for men and 2% for women.2-4 OSA incurs high health costs,4 but is often not 
adequately treated.4, 5 Continuous Positive Airway Pressure Therapy (CPAP) is the gold 
standard treatment for moderate to severe OSA. However the therapy is consistently 
associated with suboptimal adherence rates.5, 6 It has been estimated that 15 to 30% of 
patients do not accept CPAP treatment from the outset.5 Of those that do initially accept 
the treatment, 25 - 50% of patients fail to adhere optimally to CPAP.6 Patients still using 
CPAP in the long term (up to 5 years) can be expected to use their CPAP machine, on 
average, between 4 and 5 hours per night.7-11  
CPAP is an often difficult treatment and requires considerable alteration of a patient’s 
lifestyle. Side effects of the treatment may include skin irritation, nose stuffiness, air 
leaks around the mask, claustrophobic reactions to the mask, problems with 
spontaneous intimacy with the bed partner, and the noise of the machine.6 This side 
effect profile led to the belief within the literature that biomedical factors and the mask 
interface were the source of the problem. However, modifications to the CPAP device 
that have reduced many of these side effects have produced only small improvements in 
objective adherence to this treatment.12, 13 In fact, there is inconsistent evidence to 
suggest that side effects predict patient adherence. Further, linear combinations of 
biomedical indices, including Body Mass Index (BMI), Respiratory Disturbance Index 
(RDI)/Apnoea-Hypopnoea Index (AHI) and CPAP pressure, rarely predict more than 10 
to 15% of the variance in CPAP adherence.7  
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Indices of the severity of OSA, for example, RDI (a measure of the number of 
respiratory disturbances, namely, apnoeas and hypopnoeas, per hour of sleep), are not 
reliably correlated with patients’ reported subjective symptom severity and quality of 
life.2, 14  This indicates that a patients’ subjective perception of the problem may not 
necessarily reflect the objective severity of the illness, nor their need for treatment. The 
primary goal of this paper is to present a psychological model of CPAP adherence that 
predicts patient acceptance and adherence to treatment.  
Recent studies have begun to investigate the utility of psychological models in the 
prediction of CPAP acceptance and subsequent adherence.13, 15-19 Patients begin to 
develop expectations and beliefs regarding OSA and CPAP treatment even before 
taking the treatment home.20 Their subjective experience of the treatment, including 
their propensity to report subjective benefits and side-effects (or barriers) of CPAP use 
may be influenced greatly by these early belief systems. This could explain why 
objective adherence early in the treatment process is among the strongest predictors of 
subsequent use,15 rather than biomedical indices of disease severity.7 Simply, patients 
will not adhere to the treatment if they have developed expectations and beliefs 
regarding the treatment which reduce the likelihood that they will try to accept it in the 
first place.  
We propose the Health Belief Model (HBM)21 as a conceptual basis for understanding 
patient motivations to accept, and subsequently adhere to CPAP. This model is 
predictive of preventative health behaviours (such as wearing a bicycle helmet), and has 
widespread use in predicting health behaviours in other domains.21, 22 HBM is inclusive 
in its assessment of potential predictors of adherence, as it allows for the inclusion of 
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demographic variables (class, gender and age), psychological and psychosocial 
influences on subsequent action. 
HBM proposes that the patients readiness to act is contingent on their perceived 
susceptibility to illness consequences if left untreated (risk perception), and the 
perceived seriousness of their illness (impact on current functioning). The patient’s 
belief in the benefit of the proposed treatment is based on their weighting of the 
perceived benefits to their health if they adhere to the treatment (outcome expectancies) 
against the perceived barriers to action (such as potential side effects of the treatment).  
Patients’ self-efficacy (confidence)22 in being able to use the treatment in the face of 
barriers, as well as the presence of a cue to action, such as advice from a doctor, 
encouragement from the spouse, or a mass media campaign21, 22 are also important in the 
model. 
Figure 1 provides a modified conceptual model of CPAP acceptance and adherence 
using HBM constructs.21 Biomedical and psychological variables are conceptualised as 
having an influence on patients’ perceived risk of negative health outcomes, perceived 
severity of the disorder, as well as their weighing of potential benefits and barriers 
which could affect their acceptance of the treatment. However, biomedical and 
psychological variables are not expected to have a direct influence on treatment 
acceptance themselves. Self-efficacy is expected to be associated with patients’ 
perceived benefits of using the treatment (outcome expectancy). HBM predictors of 
perceived risk, severity, benefits and barriers, in the presence of a cue to action, are 
expected to directly predict acceptance of CPAP, which will in turn feed back to the 
degree to which patients perceive benefits and barriers to treatment, as well as their 
perceived disease severity and risk. CPAP acceptance, in combination with the feedback 
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loop to these HBM constructs will predict which patients will continue to adhere to 
CPAP treatment at home. 
 
INSERT FIGURE 1 HERE 
 
One recent study utilised Health Beliefs Model (HBM) constructs in predicting CPAP 
use.23  HBM constructs of benefits and barriers were found to be better predictors of 
CPAP adherence than the objective severity measures of Respiratory Disturbance Index 
(RDI), BMI and CPAP pressure. These findings lend support to the use of HBM 
constructs in the prediction of CPAP adherence. Moreover, these constructs were 
predictive after only one night of CPAP experience, indicating that the model may be of 
use in the early prediction of CPAP acceptance and adherence. 
The purpose of this study was to investigate HBM constructs in the prediction of CPAP 
adherence early in the treatment process, that is, after a diagnosis of OSA but prior to 
starting CPAP. The literature to date has been weak regarding good measures of these 
constructs.  We therefore used only existing, validated, measures of constructs from the 
model  namely self-efficacy, perceived risk (susceptibility), functional outcomes 
(severity) and outcome expectancies (benefits) will be utilised. We expected that 
measurement of self-efficacy, perceived risk, functional outcomes and outcome 
expectancies will provide a better psychological predictive model of CPAP acceptance 
and adherence than biomedical indices which have been investigated to date.  
METHODS 
Participants 
Participants were consecutive patients diagnosed with Obstructive Sleep Apnoea1, 3  
recruited through a major public hospital, in Brisbane, Australia. Patients were referred 
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to the hospital by their General Practitioner. Additional inclusion criteria included a 
recommendation by the treating sleep physician for CPAP treatment and that the patient 
had not tried CPAP treatment before. Exclusion criteria included being less than 18 
years of age or an inability to give informed consent (due to intellectual impairment or 
severe mental illness). The sample consisted of 77 patients (47 males and 30 females) 
with a mean age of 55.25 years old (SD=12.39, range= 26-80 years). Mean Body Mass 
Index (BMI) was 35.11 (SD=8.30, range= 19.5-56) and the mean Respiratory 
Disturbance Index (RDI) was 38.36 (SD=25.85, range= 5.6-124). 54.5% of the patients 
were married, 11.8% were in a relationship but not married and 19.5% were single. 
14.3% of participants did not indicate their relationship status. All participants gave 
informed consent to participate. 
Materials 
Participants completed a questionnaire battery that consisted of demographic questions, 
including age, marital status and whether they had used CPAP before. This information 
was verified against medical records. The questionnaires consisted of the following 
questionnaires;  
Epworth Sleepiness Scale (ESS)24: The ESS is a measure of subjective daytime 
sleepiness used for patients with OSA. Eight items are rated on a scale from 0 to 3 (0 = 
would never doze, 3 = high chance of dozing). Total scores range between 0 and 24 
with higher scores indicating greater propensity to fall asleep in different situations. It 
has norms available for the mild, moderate and severe categories of sleep apnoea. In 
samples of OSA, it has high internal consistency24 and correlates well with objective 
measures of sleep latency.25 
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Functional Outcomes of Sleep Questionnaire (FOSQ)26: The FOSQ is a 30 item survey 
of general quality of life in OSA and is a measure of perceived severity. 30 items 
assessing five domains including activity level, vigilance, intimacy, general productivity 
and social outcomes are rated on a likert scale ranging from 1 to 4 (1= yes, extreme 
difficulty, 4=no difficulty). Lower scores represent greater impairment in functioning. A 
mean centred total score representing total functional difficulties related to sleepiness 
can be calculated. Internal consistency estimates range from .81 to .90 for the subscales 
and .95 for the total score. 
Self-Efficacy Measure for Sleep Apnea (SEMSA)27: The SEMSA is a 26 item 
questionnaire assessing CPAP adherence related cognitions. The measure is divided into 
three subscales which directly measure three constructs of the HBM self-efficacy, risk 
perception and outcome expectancy. Items are rated on a likert scale from 1 to 4 with 
higher scores indicating greater perceived self-efficacy, greater risk perception and 
higher outcome expectancies with treatment, respectively. Internal consistencies range 
from .85 to .89 and factor analysis confirms the three independent subscales. 
Depression Anxiety Stress Scales (DASS21)28: The DASS is a 21 item self-report 
measure of symptoms of state anxiety, depression and stress rated on a likert scale from 
0 to 3 (0=did not apply to me at all, 3=applied to me very much or most of the time). 
Higher scores indicate higher severity ratings of depression, anxiety or stress symptoms 
over the past week. The DASS21 has good internal consistency estimates ranging from 
.73 to .81 and the depression and anxiety subscales correlate well with common 
Depression and Anxiety Inventories. 
Physiological Indices: Participants underwent a standard clinical polysomnography 
(PSG) scored by trained sleep scientists using recommended guidelines.3 Air flow was 
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measured using both nasal pressure and and naso-oral thermistors. Apnoea was defined 
as a reduction of both nasal pressure and thermistor to below 10% of baseline for ten 
seconds or greater. The presence of respiratory effort was determined by inductive 
plethysmography and diaphragm electromyography (EMG). Hypopnoea was defined as 
a discernible reduction (approximately 30% below baseline) of both nasal pressure 
and/or thermistor for 10 seconds or greater. These events were scored when they were 
associated (terminated) in an arousal and/or a desaturation of 3% or greater. 
Measures attained prior to, and during the diagnostic PSG for this study included, 
Respiratory Disturbance Index (RDI), Arousal Index (AI), percentage of total sleep time 
spent below 80% blood oxygenation (< 80% SaO2) and average minimum blood 
oxygenation during overnight PSG (Min SaO2). Body Mass Index (BMI) was calculated 
based on height and weight measurements (kg/m2). A CPAP titration PSG 
approximately 2 weeks following the diagnostic PSG allowed for the calculation of 
therapeutic CPAP pressure (cmH2O) required to maintain patent airways throughout 
sleep. The pressure was titrated to a level that reduced the patient’s RDI to less than 5 
events per hour. 29 
Procedure 
This study had ethical approval Human Research Ethics Committees of the University 
of Queensland and the Prince Charles Hospital Health Services District. Patients who 
met the inclusion criteria for the study were invited to participate in this research during 
their follow-up appointment with their sleep physician following their diagnostic PSG. 
Their diagnosis of OSA was explained to them in detail, and the recommended 
treatment option (CPAP) was described. An appointment for a CPAP titration study was 
made and patients were then given the questionnaire battery to complete at home.  
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Questionnaires were accompanied by a stamped, addressed envelope. Mean adherence 
was assessed through a mail out approximately 4 months after the patients’ diagnostic 
PSG, asking them to indicate the meter reading on their CPAP machine (Mean 
days=122). This mail out coincided as close as possible to a standard clinic with nurses 
at the Sleep Centre 12 weeks post-treatment initiation (Mean days=136). This face to 
face review between the nurse and the patient consisted of a machine reading assessing 
adherence, and troubleshooting problems encountered with the treatment. Patients who 
experienced difficulty with identifying the meter on their machine were assessed for 
adherence at this standard clinic. All meter readings collected during the mail out were 
compared to the data collected at the nurse clinic to ensure patients were providing 
accurate and representative adherence data. After the nurse clinic, patients were 
encouraged to call the Centre and their mask supplier if further problems emerged. 
From the 2 month standard nurse clinic onwards, telephone consultations with the 
nurses (initiated by the patient) were the primary means by which any further contact 
with the patient occurred. 
Patients who did not start using CPAP within the follow-up period were recorded as 
having a mean adherence rate of zero.  
Data Analyses 
All data analyses were conducted using SPSS for Windows version 13.0. Relationships 
between predictors with mean hours of CPAP use per night (adherence) were assessed 
using Pearson’s product moment correlation coefficients, t-tests and analysis of variance 
(ANOVA). Spearman’s rank correlations were calculated for variables violating 
assumptions of normality and linearity (RDI, min SaO2, AI and < 80% SaO2). Higher 
order relationships between biomedical and HBM predictors were assessed using 
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multiple regression analyses. Inspection of the residuals plot indicated that the 
assumption of homoscedasticity of residuals was met. The assumption of bivariate 
normality was also met. Cook’s distance, an estimate of the change in regression 
coefficients should cases be removed were not significant. Tolerance levels did not fall 
below acceptable levels, indicating that collinearity and singularity were not present.30 
Therefore all cases were retained for all analyses. FOSQ total score is derived from 
subscales all underpinning the “perceived OSA severity” construct, therefore to 
maintain statistical power and minimise use of extraneous overlapping variables, the 
total score was entered into the regression equation instead of the individual subscales. 
26 Tolerance levels were checked, and there was no evidence that collinearity or 
singularity of variables was present. 
Of the 77 participants who participated in this study, 9 cases were found to have 
missing physiological data or incomplete questionnaires. Inspection of the data file 
suggested that missing data was random, as supported by no significant differences in 
age, gender, BMI, RDI, ESS or adherence between missing and complete data sets. 
Therefore, cases with missing data were deleted listwise for the multiple regression 
analysis, leaving 68 cases for analysis. An a priori power analysis indicated that a 
minimum 64 participants would be required to detect a “moderate” effect size of r=.30 
if power is set at .80 and α=.05 (one-tailed). Therefore the current study attained an 
adequate sample size to detect significant effects if they exist.  
 
RESULTS 
Adherence at 4 month follow-up and baseline CPAP pressure and ESS scores are 
presented in Table 1. 14 patients (18%) received adherence ratings of 0 as they had not 
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initiated CPAP in the follow-up period, 21 patients (27%) had average meter readings 
between 1 and 4.5 hours per night, 35 patients (45%) had meter readings between 4.5 
and 8.0 hours per night, and the remaining 7 patients (10%) had meter readings between 
8.0 and 11.1 hours per night.  
TABLE 1 ABOUT HERE 
 
Multiple regression analyses were conducted to assess the relative importance of HBM 
predictors in explaining CPAP adherence with biomedical indices included and then 
removed from the analyses. As demonstrated in Table 2, HBM predictors (risk, outcome 
expectancy, FOSQ and self-efficacy) and biomedical indices (RDI, AI, BMI, ESS, Min 
SaO2 and percent time below 80% SaO2) together explained a significant 31.8% of the 
variance in CPAP adherence, R=.56, F(10, 57)=2.66, p=.01. Risk and outcome 
expectancy explained the most variance in adherence (p<.05), followed by FOSQ total 
score (p=.065). Self-efficacy did not contribute to adherence in the model, nor did any 
of the biomedical indices.   
 
TABLE 2 ABOUT HERE 
 
Contrary to expectation, lower perceived risk of negative health consequences was 
associated with greater adherence in the context of the Health Beliefs Model. When 
considered in a bivariate relationship with adherence it was not a significant predictor. 
The bivariate correlation between perceived risk and adherence is provided in Figure 2. 
 
FIGURE 2 ABOUT HERE 
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To determine the contribution of HBM predictors in adherence without the inclusion of 
biomedical predictors, a regression was completed with risk, outcome expectancy, self-
efficacy and FOSQ total score as predictors of CPAP adherence (see Table 3). These 
four constructs explained a significant 21.8% of the variance in CPAP adherence 
(R=.48, F(4, 70)=4.88, p=.002). Risk, outcome expectancy and FOSQ total score all 
explained a significant and unique proportion of the variance in adherence (all p<.05). 
Self-efficacy did not explain a significant proportion of the variance in adherence.  
 
 TABLE 3 ABOUT HERE 
 
Significant correlations were found between adherence and HBM constructs measured 
prior to the patient having tried CPAP (see Table 4). Higher mean use of CPAP per 
night was associated with greater outcome expectancy of treatment, lower pretreatment 
activity levels, lower self-rated intimacy levels, and lower general productivity 
throughout the day. Significant inter-correlations between the HBM constructs were 
also found, with self-efficacy highly correlated with greater expected benefits with 
treatment and higher perceived risk of negative health consequences. As demonstrated 
in Table 4, higher risk perception and higher outcome expectancies with treatment were 
associated with greater functional limitations in the areas of activity, vigilance, 
intimacy, general productivity and social outcome.  
 
TABLE 4 ABOUT HERE 
 
There were no significant differences between males and females in their mean 
adherence, t(75)=.29, p=.77, pη2=.001. There was no difference in adherence between 
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individuals of different relationship status F(3, 62)=.90, p=.45, pη2=.04. As expected, 
there was no significant direct relationship between adherence and age, BMI, CPAP 
pressure, ESS, RDI, Min SaO2, AI, and percent time spent below 80% SaO2 (see Table 
5). Furthermore, there were no direct significant relationships between adherence and 
psychological variables of depression (r=.07, p=.58), anxiety (r=-.08, p=.52) and stress 
(r=.04, p=.78). 
 
TABLE 5 ABOUT HERE 
 
Inspection of inter-correlation matrices revealed that higher BMI prior to treatment was 
associated with greater perceived risk r=.27, p<.05, lower activity levels r=-29, p<.05, 
poorer vigilance r =-.23, p<.05, lower productivity throughout the day r=-.23, p<.01 and 
higher depression r=.33, p<.01, anxiety r=.36, p<.01, and stress scores r=.32, p<.01. 
Higher ESS was associated with greater perceived risk, r=.29, p<.05, higher outcome 
expectancy with treatment, r=.27, p<.05, lower activity levels, r=-.42, p<.001, poorer 
vigilance r=-.58, p<.01, greater intimacy related concerns r=-.30, p<.05, lower general 
productivity r=-.43, p<.01 and a poorer self-rated social outcome r=-.38, p<.01. 
 
DISCUSSION 
The findings of this study support the utility of the HBM in the early prediction of 
CPAP adherence.23 Patient’s outcome expectancies prior to using CPAP, perception of 
risk, as well as perceived functional limitations due to sleepiness, such as in the areas of 
intimacy, activity levels and general productivity, all uniquely predicted CPAP 
initiation and adherence. As supported by a growing evidence base, biomedical indices 
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of disease severity did not predict more than 10% of the variance in CPAP adherence 
when HBM variables were included in regression models.7, 23  
The HBM predictors alone explained 21.8% of the variance in CPAP adherence, whilst 
biomedical and HBM predictors together explained 31.8% of variance in CPAP 
adherence. This extends on previous research investigating prediction before18 and after 
experience with CPAP.13, 15, 19 The fact that outcome expectancy prior to trying CPAP, 
as well as low perceived activity levels, low general productivity and intimacy concerns 
predicted use of the treatment four months down the track has great significance in 
terms of early identification and support of patients with factors which are associated 
with low adherence.  
Physiological and disease severity variables such as RDI, AI and drops in blood 
oxygenation during sleep were unimportant in the early prediction of CPAP adherence. 
This supports research suggesting that the patient’s perceived need for treatment is not 
directly associated with objective measures of the severity of the disorder (their 
objective need for treatment).2, 14 If patients do not see themselves as having limitations 
in functioning as a direct result of the disorder, and if expectations for improvements in 
these functional limitations are low, then consistent CPAP use is unlikely. The present 
study found that depression, anxiety and stress did not individually predict CPAP 
adherence. 
Epworth Sleepiness Score was not a significant predictor of CPAP adherence, despite 
its prevalent use in sleep medicine as an index of subjective sleepiness. ESS measured 
prior to CPAP treatment is an inconsistent predictor of adherence across the literature. 
Some studies have found it to predict adherence 31 and patient self-referrals for CPAP 
treatment. 32 Other studies report no effect of ESS score prior to treatment on 
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determining CPAP compliance. 13, 33 However, studies assessing changes in patient 
perceptions post-treatment initiation have found that improved ESS score often predicts 
current CPAP use. 9, 17, 31 Thus, this study supports research suggesting that initial ESS 
score, along with many other biomedical indices of disease severity, are inconsistent 
early predictors of CPAP adherence. However changes in these scores with treatment 
may be useful in prediction later on. 
Contrary to our expectation, lower perceived risk of negative health consequences if 
OSA was untreated was associated with greater adherence. This finding is somewhat 
perplexing given the high relationships between subjective functional limitations due to 
sleepiness and greater adherence, as well as higher outcome expectancies with higher 
adherence rates. The sample utilised in this study displayed similar demographic and 
adherence rates as previous studies,5, 6, 8-11, 15, 23 suggesting that this study captured a 
fairly “typical” OSA population. Therefore, these findings are unlikely to be attributable 
to sampling error. Further investigation of this finding is clearly needed.  
One avenue of investigation may be in the context of OSA as a “lifestyle disease”, with 
associations with other health problems such as diabetes, heart disease and obesity. 
Patients may be overwhelmed with several negative health messages and treatment 
regimes, and this may serve to decrease rather than increase motivation to adhere to 
treatment. Coordination of health services and prioritising treatment goals for individual 
patients to address one or two key underlying problems, such as poor diet and lack of 
exercise, may be more successful and less overwhelming to the patient than the prospect 
of medication, CPAP and potentially surgery to target these issues individually. 
Limitations of this study are directly tied in with the directions for future research. This 
study constituted an investigation of the HBM with measures that were available, 
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namely, self-efficacy, perceived risk (susceptibility), functional outcomes (severity) and 
outcome expectancies (benefits). A modest sample size was utilised in the study, 
however confidence intervals around the outcome variables and a priori power analysis 
indicated that the sensitivity to detect important relationships with adherence was 
adequate. The use of self-report measures of HBM constructs may represent another 
limitation of this study, however the use of validated measures overcomes some of the 
subjectivity associated with this. Moreover, beliefs testing can only occur through self-
report measures. We have developed OSA specific measures for the barriers and cues to 
action constructs to fully assess the power of HBM constructs in the early prediction of 
CPAP initiation and adherence in future research. The potential clinical applications of 
a well described HBM model would include the development of cut-off points for 
different expected levels of adherence to treatment (based on arborescence analysis, for 
example).  
The finding that motivations to use CPAP are associated with patients perceptions of 
disease severity and outcome expectancies, rather than objective measures of severity 
(such as RDI, AI and oxygen desaturation) support a call in the literature for the 
identification of psychological predictors of CPAP adherence that are amenable to 
intervention.7, 15, 34 Our findings suggest that perceptions of risk, outcome expectancies 
with treatment, and functional limitations on daily life are important early predictors of 
initiation and continued use of CPAP. Early identification of these beliefs, and 
assistance in overcoming barriers to acceptance by facilitating the development of 
realistic and positive expectations for improvements in daily life as a result of using the 
treatment, will increase adherence to CPAP therapy.  
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Figure 1. A conceptual model of CPAP adherence (modified from Clark & Becker, 1998)21 
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Figure 2: Scatterplot and correlation between perceived risk and adherence 
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Tables 
 
Table 1: Adherence, CPAP pressure and ESS 
 
 
 Mean Standard Deviation  Range 
Adherence 
(mean hours/night) 
4.57 +2.87 0 - 11.10 
CPAP pressure (cmH2O) 11.68 +2.84 6 - 19 
ESS 11.93 +5.22 2 - 21 
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Table 2: Multiple regression analysis including HBM Constructs and Biomedical Indices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Beta () 
Confidence 
Interval (CI) 
semi-partial 
correlation (sr2) t value 
Biomedical Indices:      
RDI  .05  .02 .19 
AI  -.17  -.08 -.70 
BMI  .02  .01 .13 
ESS  -.02  -.01 -.13 
Min SaO2  -.02  -.01 -.11 
<80% SaO2  -.19  -.12 -1.13 
 
HBM Indices:   
 
  
Risk  -.46 -.75 to -.17 -.34 -3.06** 
Outcome Expectancy .44 .13 to .75 .296 2.71** 
FOSQ total -.30 -.61 to .01 -.21 -1.88 
Self-efficacy .01  .004 .04 
  R=.56**    
**p<.01      
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Table 3: Multiple regression analyses with HBM Constructs alone 
 
 
 
 
 
 Beta () 
Confidence 
Interval (CI) 
semi-partial 
correlation (sr2) 
 
t value 
Risk -.49 -.76 to -.22 -.37 -3.45** 
FOSQ total -.35 -.60 to -.10 -.28 -2.64** 
Outcome Expectancy  .35 .06 to .64 .24 2.27* 
Self-Efficacy  .04  .04 .327 
 
 
R=.467** 
   
* p<.05 
**p<.01  
   
 26
Table 4: Bivariate correlations between HBM constructs and adherence 
 
 
FOSQ 
Total 
Score 
 
Risk Outcome 
Self-
Efficacy Activity Vigilance Intimacy 
General 
Productivity 
Social 
Outcome 
Adherence -.23* -.11 .25* .19 -.23* -.13 -.27* -.23* -.18 
Perceived 
Risk 
 
-.57** . .55** .31** -.54** -.49** -.38** -.60** 
 
-.40** 
Outcome 
Expectancy 
 
-.45** . . .59** -.45** -.29* -.37** -.48** 
 
-.30* 
Self-Efficacy 
 
-.29* . . . -.33** -.15 -.24 -.30* 
 
-.22 
*p<.05          
**p<.01          
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Table 5: Bivariate correlations between demographic and disease severity variables with adherence 
 
 Age BMI 
CPAP 
pressure 
 
ESS 
Min 
SaO2 AI 
<80% 
SaO2 RDI 
Adherence 
(mean hrs/ 
night) 
-.12 
 
-.08 
 
-.16 
 
 
.06 .20† 
 
-.13† 
 
-.06† 
 
-.13† 
 
         
†=rank correlations         
  
